908 Devices Inc.
NASDAQ:MASSMedical - Devices
+$0.22 today
- Market cap
- $395.86M
- Beta
- 0.64
- P/E (TTM)
- -9.0
- EPS (TTM)
- -$0.97
Volume 0.25M
Average 0.27M
MASS Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
908 Devices Inc.NASDAQ: MASS
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $1.14M fell 11.8% year over year, behind the -7.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.0% from the prior quarter. Over 3 fiscal years it compounded at +40.4% a year.
Context
- Depreciation & amortization amounted to 7.9% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -11.8% toward the trailing-twelve-month pace of -7.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 4.47M USD
- Year-over-year change
- -4.6%
- 4-year CAGR
- +48.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.47M | -4.6% |
| FY2024 | 2024-12-31 | 4.68M | +96.4% |
| FY2023 | 2023-12-31 | 2.38M | +47.7% |
| FY2022 | 2022-12-31 | 1.61M | +74.5% |
| FY2021 | 2021-12-31 | 925K | — |
Depreciation & Amortization vs competitors
How MASS compares with its peers on the latest reported figures
- MASS's LTM Mar 2026 depreciation & amortization of $4.32M is the lowest of the 3 companies compared; the peer median is $236.56M.
- Its year-over-year change of -7.0% is the lowest of 3, against a peer median of +0.9%.
- Depreciation & amortization amounts to 7.5% of revenue for MASS, versus a peer median of 6.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $271M | -5.2% | -3.1% | 3.7% | |
| LTM Jun 2026 | $202.13M | +7.0% | -2.4% | 9.6% | |
| LTM Mar 2026 | $4.32M | -7.0% | +40.4% | 7.5% | |
| Peer median (excluding MASS) | $236.56M | +0.9% | -2.8% | 6.6% | |
Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 42.21M | 46.85M | 50.23M | 59.63M | 56.2M |
| Cost of Revenue | 18.97M | 20.83M | 24.91M | 29.71M | 29.4M |
| Gross Profit | 23.23M | 26.02M | 25.32M | 29.93M | 26.8M |
| Gross Margin | 55.0% | 55.5% | 50.4% | 50.2% | 47.7% |
| Research & Development | 13.07M | 17.53M | 21.9M | 25.5M | 13.8M |
| Selling, General & Admin | 32.24M | 43.88M | 0 | 0 | 37.18M |
| Operating Expenses | 45.3M | 61.41M | 68.08M | 106.64M | 50.98M |
| Depreciation & Amortization | 925K | 1.61M | 2.38M | 4.68M | 4.47M |
| EBITDA | (20.76M) | (31.82M) | (40.27M) | (43.88M) | (28.88M) |
| EBITDA Margin | -49.2% | -67.9% | -80.2% | -73.6% | -51.4% |
| Operating Income | (22.07M) | (35.38M) | (42.76M) | (76.72M) | (24.18M) |
| Operating Margin | -52.3% | -75.5% | -85.1% | -128.7% | -43.0% |
| Interest Income | 548K | 2.03M | 6.48M | 4.49M | 4.14M |
| Interest Expense | 486K | 129K | 201K | 0 | 0 |
| Other Income / Expenses | (100K) | 1.82M | 6.15M | 4.23M | (9.16M) |
| Income Before Tax | (22.17M) | (33.56M) | (36.61M) | (72.49M) | (33.34M) |
| Pre-Tax Margin | -52.5% | -71.6% | -72.9% | -121.6% | -59.3% |
| Income Tax Expense | 0 | 0 | (211K) | (282K) | (66K) |
| Net Income | (22.17M) | (33.56M) | (36.4M) | (72.21M) | (36.64M) |
| Net Margin | -52.5% | -71.6% | -72.5% | -121.1% | -65.2% |
| EPS (Basic) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| EPS (Diluted) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| Weighted Avg Shares | 27.96M | 31.49M | 32.21M | 34.08M | 36.22M |
| Weighted Avg Shares (Diluted) | 27.96M | 31.49M | 32.24M | 34.08M | 38.92M |
908 Devices Inc.
NASDAQ:MASS
Intrinsic Alpha fair value
Locked
Current Price
$9.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.